Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab-Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma.
Journal: Cancer medicine
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Xia T, Cheng C, Meng Y, et al. (2026). "Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab-Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma.". Cancer medicine. https://doi.org/10.1002/cam4.72491